Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aldesleukin to Enhance HIV-Specific Immunity
NCT00038259Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
aldesleukin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00038259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038259.